Trial participants experienced different levels of % total body weight loss depending on the dose: Percentage of total body weight loss on retatrutide After 48 weeks , 83% of patients taking 12 mg lost at least 15% of their body weight , compared to just 2% of those who were on a placebo
This removes financial considerations from clinical decision-making, allowing providers and users to focus exclusively on optimal treatment protocols rather than cost-constrained compromises limiting clinical effectiveness
Great company, good quality
Stopping before 12 months significantly increases the likelihood of weight regain without having built the foundation to prevent it
Du J, Liu B, Zhao T, Xu X, Lin H, Ji Y, Li Y, Li Z, Lu C, Li P, Zhao H, Li Y, Yin Z, Ding X